Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Temozolomide, Bevacizumab, Lithium and Radiation Treatment for Newly Diagnosed High Grade Glioma: A Phase II Study

NCT01105702 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01105702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Temozolomide, Bevacizumab, Lithium and Radiation Treatment for Newly Diagnosed High Grade Glioma: A Phase II Study
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2010
Completion date
April 30, 2015
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer